chloramphenicol has been researched along with Disease Models, Animal in 61 studies
Amphenicol: Chloramphenicol and its derivatives.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The influence of photochemically activated 40% solution of Levomecol ointment toward the tissue apoptosis while occurrence of ischemic complications of diabetes mellitus was studied in experiment on 184 adult mongrel white male rats weighted 250-310 g." | 7.73 | [The influence of photochemically activated 40% solution of levomecol ointment toward apoptosis in muscles of the rats posterior extremities in inflammatory-purulent complications of diabetes mellitus]. ( Babenkov, HD; Dolhopolov, VV; Peleshenko, OS; Potiĭ, VV; Shypilov, KV, 2006) |
| "We utilized an animal model of brain abscess to evaluate the efficacy of penicillin with and without chloramphenicol in preventing the development of brain abscess." | 5.27 | Treatment of experimental brain abscess with penicillin and chloramphenicol. ( Costello, GT; Haley, EC; Rodeheaver, GT; Scheld, WM; Winn, HR, 1983) |
| "To evaluate the efficacy of corneal collagen cross-linking (CXL) with photoactivated riboflavin (PACK-CXL) as primary therapy for Staphylococcus aureus-induced corneal ulcers in a rabbit model." | 3.81 | Efficacy of Primary Collagen Cross-Linking with Photoactivated Chromophore (PACK-CXL) for the Treatment of Staphylococcus aureus-Induced Corneal Ulcers. ( Bahar, I; Gal-Or, O; Pillar, S; Rock, O; Tal, K; Zahavi, A, 2015) |
| "The influence of photochemically activated 40% solution of Levomecol ointment toward the tissue apoptosis while occurrence of ischemic complications of diabetes mellitus was studied in experiment on 184 adult mongrel white male rats weighted 250-310 g." | 3.73 | [The influence of photochemically activated 40% solution of levomecol ointment toward apoptosis in muscles of the rats posterior extremities in inflammatory-purulent complications of diabetes mellitus]. ( Babenkov, HD; Dolhopolov, VV; Peleshenko, OS; Potiĭ, VV; Shypilov, KV, 2006) |
| "Aldose reductase catalyzes the NADPH-linked reduction of hexoses to their respective sugar-alcohols, which are involved in the pathogenesis of "sugar-cataracts"." | 3.68 | Effects of G-6-PD deficiency, experimentally induced or genetically transmitted, on the sorbitol pathway activity. In vitro and in vivo studies. ( Alvarez, A; Chávez, M; Chávez-Anaya, E; Medina, C; Medina, MD; Mendoza, R; Ramírez, MG; Sáenz, G; Vaca, G; Vargas, M, 1992) |
| "The therapy of Proteus mirabilis meningitis with gentamicin alone and in combination with chloramphenicol was studied in a rabbit model." | 3.66 | Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits. ( Sande, MA; Strausbaugh, LJ, 1978) |
| " Clindamycin and tetracycline were the most effective in preventing the formation of abscesses." | 3.65 | Chemotherapy of an experimental Bacteroides fragilis infection in mice. ( Nitzan, D; Walker, CB; Wilkins, TD, 1977) |
| "Chloramphenicol is a potent activator of autophagy; however, the effects of chloramphenicol on articular cartilage are unknown." | 1.51 | Intra-articular Injection of Chloramphenicol Reduces Articular Cartilage Degeneration in a Rabbit Model of Osteoarthritis. ( Cai, Y; Huang, Z; Lu, S; Shi, X; Wu, X; Xu, K; Xu, P; Yang, L, 2019) |
| "Chloramphenicol is a well-known broad-spectrum bacteriostatic antibiotic that has been used since 1949, but due to its hydrophobicity, poor penetration in skin, fast degradation, and toxicity, its application has been hindered." | 1.42 | Chloramphenicol encapsulated in poly-ε-caprolactone-pluronic composite: nanoparticles for treatment of MRSA-infected burn wounds. ( Devi, B; Kalita, K; Kalita, S; Kandimalla, R; Kataki, AC; Kotoky, J; Sharma, A; Sharma, KK, 2015) |
| "Chloramphenicol niosomes were prepared using two different ratios of cholesterol, drug and surfactant, termed as EIN-1, EIN-2 by ether injection method and their entrapment efficiency, particle size." | 1.38 | Preparation and characterization of chloramphenicol niosomes and comparison with chloramphenicol eye drops (0.5%w/v) in experimental conjunctivitis in albino rabbits. ( Hameed, A; Hussain, S; Malik, F; Perveen, G; Qureshi, F; Riaz, H; Sultan, T; Wajid, A; Yasin, MN, 2012) |
| "1." | 1.30 | Haemotoxicity of chloramphenicol succinate in the CD-1 mouse and Wistar Hanover rat. ( Andrews, CM; Fagg, R; Turton, JA; Williams, TC; Yallop, D; York, M, 1999) |
| "We utilized an animal model of brain abscess to evaluate the efficacy of penicillin with and without chloramphenicol in preventing the development of brain abscess." | 1.27 | Treatment of experimental brain abscess with penicillin and chloramphenicol. ( Costello, GT; Haley, EC; Rodeheaver, GT; Scheld, WM; Winn, HR, 1983) |
| " The first dosage achieved a peak CSF concentration of 4." | 1.27 | Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. ( Sande, MA; Scheld, WM, 1983) |
| " Up to this time, amoxicillin has not been commercially available as an injectable dosage form." | 1.25 | Pneumococcal meningitis-therapeutic studies in mice. ( Hirth, RS; Price, KE; Tsai, YH; Williams, EB, 1975) |
| "Chloramphenicol did not enhance vitamin B(12) absorption in partially pancreatectomized rats with pancreatic extract-improved vitamin B(12) malabsorption." | 1.25 | The role of the pancreas in vitamin B 12 absorption: studies of vitamin B 12 absorption in partially pancreatectomized rats. ( Deren, JJ; Toskes, PP, 1972) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (50.82) | 18.7374 |
| 1990's | 5 (8.20) | 18.2507 |
| 2000's | 8 (13.11) | 29.6817 |
| 2010's | 15 (24.59) | 24.3611 |
| 2020's | 2 (3.28) | 2.80 |
| Authors | Studies |
|---|---|
| Mata, R | 1 |
| Martínez, E | 1 |
| Bye, R | 1 |
| Morales, G | 1 |
| Singh, MP | 1 |
| Janso, JE | 1 |
| Maiese, WM | 1 |
| Timmermann, B | 1 |
| Plasencia, V | 1 |
| Borrell, N | 1 |
| Maciá, MD | 1 |
| Moya, B | 1 |
| Pérez, JL | 1 |
| Oliver, A | 1 |
| Avdeef, A | 1 |
| Tam, KY | 1 |
| Chiu, HC | 1 |
| Lee, SL | 1 |
| Kapuriya, N | 1 |
| Wang, D | 1 |
| Chen, YR | 1 |
| Yu, SL | 1 |
| Kulp, SK | 1 |
| Teng, LJ | 1 |
| Chen, CS | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Han, J | 1 |
| Kim, SJ | 1 |
| Ryu, MJ | 1 |
| Jang, Y | 1 |
| Lee, MJ | 1 |
| Ju, X | 1 |
| Lee, YL | 1 |
| Cui, J | 1 |
| Shong, M | 1 |
| Heo, JY | 1 |
| Kweon, GR | 1 |
| Wu, X | 1 |
| Cai, Y | 1 |
| Lu, S | 1 |
| Xu, K | 1 |
| Shi, X | 1 |
| Yang, L | 1 |
| Huang, Z | 1 |
| Xu, P | 1 |
| Biondo-Simões, MLP | 1 |
| Henning Júnior, L | 1 |
| Boen, BRO | 1 |
| Prado, JLD | 1 |
| Costa, LRD | 1 |
| Robes, RR | 1 |
| Ioshii, SO | 1 |
| Lagatolla, C | 1 |
| Milic, J | 1 |
| Imperi, F | 1 |
| Cervoni, M | 1 |
| Bressan, R | 1 |
| Luzzati, R | 1 |
| Di Bella, S | 1 |
| Barequet, IS | 1 |
| Harizman, N | 1 |
| Ziv, H | 1 |
| Rosner, M | 1 |
| Kalita, S | 1 |
| Devi, B | 1 |
| Kandimalla, R | 1 |
| Sharma, KK | 1 |
| Sharma, A | 1 |
| Kalita, K | 1 |
| Kataki, AC | 1 |
| Kotoky, J | 1 |
| Tal, K | 1 |
| Gal-Or, O | 1 |
| Pillar, S | 1 |
| Zahavi, A | 1 |
| Rock, O | 1 |
| Bahar, I | 1 |
| Dey, S | 1 |
| Bishayi, B | 1 |
| Jin, J | 1 |
| Ma, JX | 1 |
| Guan, M | 1 |
| Yao, K | 1 |
| Przyklenk, K | 1 |
| Undyala, VV | 1 |
| Wider, J | 1 |
| Sala-Mercado, JA | 1 |
| Gottlieb, RA | 1 |
| Mentzer, RM | 1 |
| Vaks, L | 1 |
| Benhar, I | 1 |
| Selvaraj, N | 1 |
| Lakshmanan, B | 1 |
| Mazumder, PM | 1 |
| Karuppasamy, M | 1 |
| Jena, SS | 1 |
| Pattnaik, AK | 1 |
| Yasin, MN | 1 |
| Hussain, S | 1 |
| Malik, F | 1 |
| Hameed, A | 1 |
| Sultan, T | 1 |
| Qureshi, F | 1 |
| Riaz, H | 1 |
| Perveen, G | 1 |
| Wajid, A | 1 |
| Campoy, EM | 1 |
| Mansilla, ME | 1 |
| Colombo, MI | 1 |
| Biousse, V | 1 |
| Pardue, MT | 1 |
| Wallace, DC | 1 |
| Newman, NJ | 1 |
| Chen, J | 1 |
| Barbu, E | 1 |
| Sarvaiya, I | 1 |
| Green, KL | 1 |
| Nevell, TG | 1 |
| Tsibouklis, J | 1 |
| Torba, AV | 1 |
| Babenkov, HD | 1 |
| Dolhopolov, VV | 1 |
| Potiĭ, VV | 1 |
| Shypilov, KV | 1 |
| Peleshenko, OS | 1 |
| Beam, TR | 1 |
| Vincent, PC | 1 |
| Haley, EC | 1 |
| Costello, GT | 1 |
| Rodeheaver, GT | 1 |
| Winn, HR | 1 |
| Scheld, WM | 2 |
| Sande, MA | 2 |
| Haak, HL | 1 |
| Guentzel, MN | 1 |
| Herrera, C | 1 |
| Clark, DG | 1 |
| Schweizer, RT | 1 |
| Jauris-Heipke, S | 1 |
| Leake, ER | 1 |
| Billy, JM | 1 |
| DeMaria, TF | 1 |
| Stephan, D | 1 |
| Gasser, B | 1 |
| San, H | 1 |
| Schubnel, M | 1 |
| Nabel, GJ | 1 |
| Nabel, EG | 1 |
| Ulett, GC | 1 |
| Norton, RE | 1 |
| Hirst, RG | 1 |
| Turton, JA | 2 |
| Yallop, D | 1 |
| Andrews, CM | 1 |
| Fagg, R | 1 |
| York, M | 1 |
| Williams, TC | 1 |
| Festing, MF | 1 |
| Diamanti, P | 1 |
| Strausbaugh, LJ | 1 |
| Fraser, DW | 1 |
| Wachsmuth, I | 1 |
| Bopp, C | 1 |
| Feeley, JC | 1 |
| Tsai, TF | 1 |
| Hamilton-Miller, JM | 1 |
| Tsai, YH | 1 |
| Williams, EB | 1 |
| Hirth, RS | 1 |
| Price, KE | 1 |
| Michalek, SM | 1 |
| McGhee, JR | 1 |
| Lavergne, GM | 1 |
| James, HF | 1 |
| Martineau, C | 1 |
| Diena, BB | 1 |
| Lior, H | 1 |
| Fox, JL | 1 |
| Walker, CB | 1 |
| Nitzan, D | 1 |
| Wilkins, TD | 1 |
| Kanamaru, A | 1 |
| Kosaki, M | 1 |
| Kai, T | 1 |
| Kashitani, Y | 1 |
| Nagai, K | 1 |
| Morley, A | 1 |
| Trainor, K | 1 |
| Remes, J | 1 |
| Vaca, G | 1 |
| Ramírez, MG | 1 |
| Vargas, M | 1 |
| Mendoza, R | 1 |
| Chávez-Anaya, E | 1 |
| Medina, MD | 1 |
| Alvarez, A | 1 |
| Medina, C | 1 |
| Sáenz, G | 1 |
| Chávez, M | 1 |
| Henkel, W | 2 |
| Freiesleben, H | 2 |
| Wöhrmann, W | 2 |
| Krüger, C | 1 |
| Commichau, R | 2 |
| Mertens, E | 1 |
| Henneberg, G | 2 |
| Coppi, G | 1 |
| Bonardi, G | 1 |
| Jawetz, E | 1 |
| Demello, FJ | 1 |
| Haglin, JJ | 1 |
| Hitchcock, CR | 1 |
| Campos, ME | 1 |
| Rabinovich, S | 1 |
| Smith, IM | 1 |
| Lemperle, G | 1 |
| Rudzit, EA | 1 |
| Lisitsa, LI | 1 |
| Toskes, PP | 1 |
| Deren, JJ | 1 |
| Medina Ortega, R | 1 |
| Doménech Ratto, G | 1 |
| Wolff, I | 1 |
| Yeary, RA | 1 |
| Rejniak, L | 1 |
| Prokopowicz, D | 1 |
| Kurasz, S | 1 |
8 reviews available for chloramphenicol and Disease Models, Animal
| Article | Year |
|---|---|
The eyes of mito-mouse: mouse models of mitochondrial disease.
Topics: Animals; Chimera; Chloramphenicol; Disease Models, Animal; DNA-Binding Proteins; Drug Resistance; Ey | 2002 |
Animal models for acquired bone marrow failure syndromes.
Topics: Anemia, Aplastic; Animals; Benzene; Bone Marrow Diseases; Busulfan; Chloramphenicol; Disease Models, | 2005 |
Cephalosporins in adult meningitis.
Topics: Adolescent; Adult; Animals; Bacterial Infections; Cephalosporins; Chloramphenicol; Disease Models, A | 1984 |
In vitro evidence of drug action in aplastic anemia.
Topics: Acetanilides; Anemia, Aplastic; Animals; Benzene; Cell Differentiation; Chloramphenicol; Disease Mod | 1984 |
Experimental drug-induced aplastic anaemia.
Topics: Anemia, Aplastic; Animals; Benzene; Busulfan; Chloramphenicol; Colony-Forming Units Assay; Disease M | 1980 |
Antimicrobial agents acting against anaerobes.
Topics: Aminoglycosides; Anaerobiosis; Animals; Anti-Bacterial Agents; Bacteria; Chloramphenicol; Clindamyci | 1975 |
Chemotherapy of chlamydial infections.
Topics: Animals; Anti-Bacterial Agents; Bacitracin; Bird Diseases; Birds; Chlamydia; Chlamydia Infections; C | 1969 |
[Experimental pyelonephritis, chemotherapeutic studies (review of the literature)].
Topics: Acute Disease; Ampicillin; Animals; Anti-Bacterial Agents; Chloramphenicol; Chronic Disease; Coryneb | 1971 |
53 other studies available for chloramphenicol and Disease Models, Animal
| Article | Year |
|---|---|
Biological and mechanistic activities of xanthorrizol and 4-(1',5'-dimethylhex-4'-enyl)-2-methylphenol isolated from Iostephane heterophylla.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Asteraceae; Candida albica | 2001 |
Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Disease Models, Animal; Drug Resistance, | 2007 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological | 2010 |
Development of novel antibacterial agents against methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cell Proliferation; Disease Models, Animal; D | 2012 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Chloramphenicol Mitigates Oxidative Stress by Inhibiting Translation of Mitochondrial Complex I in Dopaminergic Neurons of Toxin-Induced Parkinson's Disease Model.
Topics: Animals; Chloramphenicol; Disease Models, Animal; Herbicides; Humans; Mice; Mitochondria; Oxidative | 2019 |
Intra-articular Injection of Chloramphenicol Reduces Articular Cartilage Degeneration in a Rabbit Model of Osteoarthritis.
Topics: Aged; Animals; Anti-Bacterial Agents; Apoptosis; Cartilage, Articular; Cell Survival; Chloramphenico | 2019 |
Comparative analysis of the effects of honey, copaiba oil-resin and a commercial product (fibrinolysin, deoxyribonuclease and chloramphenicol) on second intention healing, in rats.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Chloramphenicol; Deoxyribonuclease I; Disea | 2019 |
Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Disease Models, Animal; Drug Synergism; Enterococcu | 2021 |
Healing rate of corneal erosions: comparison of the effect of chloramphenicol eye drops and ointment and high-concentration hyaluronic acid in an animal model.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Corneal Diseases; Disease Models, Animal; Epitheliu | 2014 |
Chloramphenicol encapsulated in poly-ε-caprolactone-pluronic composite: nanoparticles for treatment of MRSA-infected burn wounds.
Topics: Animals; Anti-Bacterial Agents; Burns; Cell Line, Tumor; Cell Survival; Chloramphenicol; Disease Mod | 2015 |
Efficacy of Primary Collagen Cross-Linking with Photoactivated Chromophore (PACK-CXL) for the Treatment of Staphylococcus aureus-Induced Corneal Ulcers.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Chloramphenicol; Collagen; Colony Count, Microbial; Corne | 2015 |
Effect of iNOS inhibitor LNMMA along with antibiotics Chloramphenicol or Ofloxacin in murine peritoneal macrophages regulates S.aureus infection as well as inflammation: An in vitro study.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Chloramphenicol; Cyclooxygenase 2; Cytokines; Disease | 2017 |
Inhibition of chemical cautery-induced corneal neovascularization by topical pigment epithelium-derived factor eyedrops.
Topics: Administration, Topical; Animals; Antigens, CD34; Blotting, Western; Cautery; Chloramphenicol; Chond | 2010 |
Acute induction of autophagy as a novel strategy for cardioprotection: getting to the heart of the matter.
Topics: Animals; Apoptosis; Autophagy; Chloramphenicol; Disease Models, Animal; Models, Biological; Myocardi | 2011 |
Antibacterial application of engineered bacteriophage nanomedicines: antibody-targeted, chloramphenicol prodrug loaded bacteriophages for inhibiting the growth of Staphylococcus aureus bacteria.
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Chloramphenicol; Disease Models, Animal; Drug Delive | 2011 |
Evaluation of wound healing and antimicrobial potentials of Ixora coccinea root extract.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Chloramphenicol; Ciprofloxa | 2011 |
Preparation and characterization of chloramphenicol niosomes and comparison with chloramphenicol eye drops (0.5%w/v) in experimental conjunctivitis in albino rabbits.
Topics: Animals; Chloramphenicol; Conjunctivitis, Bacterial; Disease Models, Animal; Drug Carriers; Drug Sta | 2012 |
Endocytic SNAREs are involved in optimal Coxiella burnetii vacuole development.
Topics: Animals; Cell Line; Chloramphenicol; Chlorocebus aethiops; CHO Cells; Coxiella burnetii; Cricetinae; | 2013 |
Vinylpyrrolidone-co-(meth)acrylic acid inserts for ocular drug delivery: synthesis and evaluation.
Topics: Animals; Chloramphenicol; Disease Models, Animal; Drug Carriers; Drug Evaluation; Eye; Eye Diseases; | 2005 |
[Application of photochemically activated ointment based on polyethylene oxides for treatment of peritonitis].
Topics: Animals; Anti-Infective Agents, Local; Chloramphenicol; Chlorhexidine; Disease Models, Animal; Drain | 2005 |
[The influence of photochemically activated 40% solution of levomecol ointment toward apoptosis in muscles of the rats posterior extremities in inflammatory-purulent complications of diabetes mellitus].
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Chloramphenicol; Combined Modality Therapy; Diabetes Comp | 2006 |
Treatment of experimental brain abscess with penicillin and chloramphenicol.
Topics: Animals; Brain Abscess; Chloramphenicol; Disease Models, Animal; Drug Evaluation, Preclinical; Drug | 1983 |
Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits.
Topics: Ampicillin; Animals; Chloramphenicol; Disease Models, Animal; Meningitis, Pneumococcal; Microbial Se | 1983 |
Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy.
Topics: Aging; Animals; Candida albicans; Candidiasis; Chloramphenicol; Cortisone; Cyclophosphamide; Digesti | 1982 |
Use of antibiotics for prevention of Bacteroides fragilis wound sepsis in rats.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infection | 1980 |
The effect of antibiotic treatment on the release of endotoxin during nontypable Haemophilus influenzae-induced otitis media in the chinchilla.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Chinchilla; Chloramphenicol; Disease Models, Animal; En | 1997 |
[Direct gene transfer in the rat kidney in vivo].
Topics: Acetyltransferases; Adenoviridae; Alkaline Phosphatase; Animals; Chloramphenicol; Disease Models, An | 1997 |
Combination antimicrobial therapy of acute Burkholderia pseudomallei infection in a mouse model.
Topics: Animals; Burkholderia pseudomallei; Cefpirome; Ceftazidime; Cephalosporins; Chloramphenicol; Disease | 1999 |
Haemotoxicity of chloramphenicol succinate in the CD-1 mouse and Wistar Hanover rat.
Topics: Anemia, Aplastic; Animals; Apoptosis; Blood Cell Count; Bone Marrow; Chloramphenicol; Clinical Chemi | 1999 |
Strain differences in haematological response to chloramphenicol succinate in mice: implications for toxicological research.
Topics: Analysis of Variance; Anemia, Aplastic; Animals; Blood Cells; Body Weight; Breeding; Chloramphenicol | 2001 |
Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits.
Topics: Animals; Chloramphenicol; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Antagonism; | 1978 |
Antibiotic treatment of guinea-pigs infected with agent of Legionnaires' disease.
Topics: Administration, Oral; Animals; Chloramphenicol; Disease Models, Animal; Drug Evaluation; Drug Evalua | 1978 |
Pneumococcal meningitis-therapeutic studies in mice.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Cerebellum; Cerebral Cortex; Chloramphenicol; Chlort | 1975 |
Virulence of Streptococcus mutans: an antibiotic-suppressed rat model for studies of pathogenesis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Carbenicillin; Cephalothin; Chloramphenicol; D | 1977 |
The guinea pig as a model for the asymptomatic human typhoid carrier.
Topics: Administration, Oral; Animals; Antibodies, Bacterial; Carrier State; Chloramphenicol; Disease Models | 1977 |
Effects of procainamide and chloramphenicol on acute vasospasm.
Topics: Acute Disease; Administration, Topical; Animals; Basilar Artery; Chloramphenicol; Disease Models, An | 1977 |
Chemotherapy of an experimental Bacteroides fragilis infection in mice.
Topics: Abscess; Animals; Bacteroides fragilis; Bacteroides Infections; Cephalothin; Chloramphenicol; Clinda | 1977 |
[Effects of chloramphenicol (CP) on in vitro colony-forming cell (CFU-C) in W anemic mice (author's transl)].
Topics: Anemia, Aplastic; Animals; Bone Marrow; Bone Marrow Cells; Cell Division; Chloramphenicol; Disease M | 1976 |
Residual marrow damage: possible explanation for idiosyncrasy to chloramphenicol.
Topics: Anemia, Aplastic; Animals; Bone Marrow; Bone Marrow Cells; Busulfan; Cell Count; Chloramphenicol; Di | 1976 |
Effects of G-6-PD deficiency, experimentally induced or genetically transmitted, on the sorbitol pathway activity. In vitro and in vivo studies.
Topics: Acetaminophen; Adolescent; Adult; Aged; Aged, 80 and over; Aldehyde Reductase; Animals; Black People | 1992 |
[Immunological defense and virulence of the agent in experimental chronic infection].
Topics: Animals; Chloramphenicol; Chronic Disease; Disease Models, Animal; Escherichia coli; Escherichia col | 1974 |
[Histological investigations on guinea pigs (typhoid bacteria excretors) experimentally infected with Salmonella typhi].
Topics: Animals; Bacteriuria; Carrier State; Chloramphenicol; Chronic Disease; Disease Models, Animal; Feces | 1969 |
Urease-inhibiting action of some drugs in vitro and in vivo.
Topics: Ammonia; Animals; Anti-Bacterial Agents; Ascorbic Acid; Bacitracin; Chloramphenicol; Chlortetracycli | 1970 |
Comparative study of experimental Clostridium perfringens infection in dogs treated with antibiotics, surgery, and hyperbaric oxygen.
Topics: Animals; Anti-Bacterial Agents; Cephalothin; Chloramphenicol; Clostridium perfringens; Disease Model | 1973 |
[Serum resistance and "nephropathogenicity" of E. coli. IV. Changes of virulence in vitro and in vivo].
Topics: Ampicillin; Animals; Blood Bactericidal Activity; Chloramphenicol; Chronic Disease; Disease Models, | 1974 |
Therapy of experimental staphylococcal infection with antibiotic combinations.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Disease Models, Animal; Drug Antagonism; Drug Syner | 1974 |
Depression and stimulation of host defense mechanisms after severe burns.
Topics: Animals; Burns; Chloramphenicol; Disease Models, Animal; Gentamicins; Mice; Mononuclear Phagocyte Sy | 1970 |
The role of the pancreas in vitamin B 12 absorption: studies of vitamin B 12 absorption in partially pancreatectomized rats.
Topics: Animals; Body Weight; Chloramphenicol; Cobalt Isotopes; Disease Models, Animal; Gastric Mucosa; Inte | 1972 |
[Effects of chloramphenicol on chick and rat embryos].
Topics: Abnormalities, Drug-Induced; Animals; Chick Embryo; Chloramphenicol; Disease Models, Animal; Female; | 1971 |
[Bacteriological and serological investigations on guinea pigs, experimentally infected with S. typhi (bacterial excretors)].
Topics: Agglutination Tests; Animals; Antibodies; Bacteriuria; Carrier State; Chloramphenicol; Diagnosis, Di | 1969 |
Comparative toxicity studies on glucuronide-forming compounds in icteric and nonicteric newborn Gunn rats.
Topics: Aminobenzoates; Analgesics; Aniline Compounds; Animals; Animals, Newborn; Chloramphenicol; Dapsone; | 1970 |
Morphological changes in the course of experimental salmonellosis in rabbits.
Topics: Adrenal Glands; Animals; Chloramphenicol; Disease Models, Animal | 1970 |